A plea for the creation of trophoblastic disease reference centers in France;Plaidoyer pour la creation de centres de reference des maladies trophoblastiques en France

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 29, Issue 6, 2000, Pages 538-547

  Golfier, F ^a   Frappart, L ^a   Schott, A M ^a   Raudrant, D ^a  

^a HÔTEL DIEU   (France)

Author keywords

Chemotherapy; Hydatidiform mole; Trophoblastic tumor

Indexed keywords

CHORIONIC GONADOTROPIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; VINCRISTINE;

CHORIOCARCINOMA; CLINICAL PROTOCOL; FEMALE; FRANCE; HUMAN; HYDATIDIFORM MOLE; MEDICAL INFORMATION; REVIEW; STANDARDIZATION; TROPHOBLASTIC DISEASE; TROPHOBLASTIC TUMOR; MEDICINE; OBSTETRICS; PATIENT REFERRAL; PREGNANCY; UTERUS CANCER;

FEMALE; FRANCE; HUMANS; HYDATIDIFORM MOLE; OBSTETRICS; PREGNANCY; REFERRAL AND CONSULTATION; SPECIALTIES, MEDICAL; UTERINE NEOPLASMS;

EID: 0033730734     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Maladies trophoblastiques gestationnelles
2. Recent advances in gestational trophoblastic disease
3. Hydatidiform mole: Two entities. A morphologic and cytogenetic study with some clinical consideration
4. The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations
5. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions
6. The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole
7. The diagnosis and prognosis of molar pregnancy: The experience of the National Referral Centre in London
8. Genetic studies on hydatidiform moles. I. The origin of partial moles
9. Human triploidy: Relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole
10. A prospective genetic study of complete and partial hydatidiform moles
11. Gestational trophoblastic disease. Molecular and genetic studies
12. Les maladies gestationnelles trophoblastiques persistantes: Mole et choriocarcinome
13. Incidence of invasive mole and choriocarcinoma following partial hydatidiform mole
14. Persistent gestational trophoblastic tumor after partial hydatidiform mole
15. Complete hydatidiform mole with a coexistent embryo
16. Diploid hydatidiform moles with fetal red blood cells in molar villi. 2- -Genetics
17. Diploid hydatidiform moles with fetal red blood cells in molar villi. 1-Pathology, incidence, and prognosis
18. Chorionic tumors
19. The changing clinical presentation of complete molar pregnancy
20. Recent advances in gestational trophoblastic disease
21. Very early complete hydatidiform mole
22. Androgenetic origin of hydatidiform mole
23. Dispermic origin of XY hydatidiform moles
24. Genesis of 46,XY hydatidiform mole
25. Frequency of heterozygous complete hydatidiform moles, estimated by locus-specific minisatellite and Y chromosome-specific probes
26. Predictors of persistent disease in women with complete hydatidiform mole
27. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole
28. hCG, its free subunits and its metabolites. Roles in pregnancy and trophoblastic disease
29. Criteria toward the definition of nonmetastatic gestational trophoblastic disease after hydatidiform mole
30. Evaluation of the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia
31. Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease
32. Relationship of oral contraception to development of trophoblastic tumour after evacuation of a hydatidiform mole
33. Oral contraceptives and post-molar trophoblastic tumours
34. Oral contraceptives and postmolar trophoblastic disease
35. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study)
36. Practice guidelines: Gestational trophoblastic disease
37. The relationship between HLA antibodies and the causal pregnancy in choriocarcinoma
38. Gestational and nongestational trophoblastic tumors distinguished by DNA analysis
39. The morphology, biology, and pathology of inter-mediate trophoblast: A look back to the present
40. Management of placental site trophoblastic tumors
41. Nonmetastatic gestational trophoblastic neoplasia. Role of ultrasonography and magnetic resonance imaging
42. Gestational trophoblastic disease with liver metastases: The Charing Cross experience
43. Immunodiagnosis and monitoring of gonadotrophin-producing metastases in the central nervous system
44. Risk and prognostic factors in trophoblastic neoplasia
45. Tumeurs trophoblastiques
46. FIGO: Annual report on the results of treatment in gynecological cancer
47. Tumeurs trophoblastiques
48. Treatment of high-risk choriocarcinoma
49. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989
50. Management of high-risk gestational trophoblastic disease
51. Letter: Hydatidiform mole: Two entities
52. Malignant trophoblastic neoplasms with different modes of origin
53. Evaluation of prognostic factors and staging in gestational trophoblastic tumor
54. Metastatic gestational trophoblastic disease: Prognostic factors in previously untreated patients
55. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT - 25 years experiences of KRI-TRD
56. Causes of treatment failure in gestational trophoblastic disease
57. Changes in gestational trophoblastic tumors over four decades. A Korean experience
58. 5-Day methotrexate for women with metastatic gestational trophoblastic disease
59. Fatal gestational choriocarcinoma. Clinicopathologic study of patients treated at a trophoblastic disease center
60. Recurrent gestational trophoblastic disease. Experience of the Southeastern Regional Trophoblastic Disease Center
61. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy
62. Gestational trophoblastic disease. A comparative study of the results of therapy in patients with invasive mole and with choriocarcinoma
63. Gestational trophoblastic tumors - A report of experiences
64. Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors